Close Menu

NEW YORK – Eutropics Pharmaceuticals has been awarded a $500,000 Small Business Innovation Research grant from venture capital firm MassVentures to explore clinical applications for its PraediCare Dx cancer drug response companion diagnostic platform.  

The Cambridge, Massachusetts-based firm also plans to commercialize a new version of its in vitro diagnostic platform for drug treatment response in the near future, which the firm said will directly detect heterodimer protein complexes in a patient's cancer cells.

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.